Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus

被引:23
|
作者
Papp, Ferenc [1 ,2 ]
Batista, Cesar V. F. [3 ]
Varga, Zoltan [1 ]
Herceg, Monika [1 ]
Roman-Gonzalez, Sergio A. [3 ]
Gaspar, Rezso [1 ]
Possani, Lourival D. [3 ]
Panyi, Gyorgy [1 ,2 ]
机构
[1] Univ Debrecen, Dept Biophys & Cell Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Biophys & Cell Biol,Res Ctr Mol Med, H-4012 Debrecen, Hungary
[3] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico
关键词
Kv1.3; Kv1.2; Toxin; Scorpion; GATED POTASSIUM CHANNELS; HUMAN T-LYMPHOCYTES; K+ CHANNEL; PROTEOMIC ANALYSIS; SCORPION TOXINS; BINDING-SITE; ALPHA; INACTIVATION; ION; NOMENCLATURE;
D O I
10.1016/j.toxicon.2009.05.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using high-performance liquid chromatography Tst26, a novel potassium channel blocker peptide, was purified from the venom of the Brazilian scorpion Tityus stigmurus. its primary structure was determined by means of automatic Edman degradation and mass spectrometry analysis. The peptide is composed of 37 amino acid residues and tightly folded through three disulfide bridges, similar to other K+ channel blocking peptides purified from scorpion venoms. It contains the "essential dyad" for K+ channel recognition comprised of a lysine at position 27 and a tyrosine at position 36. Electrophysiological assays revealed that Tst26 blocked hKv1.2 and hKv1.3 channels with high affinity (K-d = 1.9 nM and 10.7 nM, respectively) while it did not affect several other ion channels (mKv1.1, hKv1.4, hKv1.5, hERG, hIKCa1, hBK, hNav1.5) tested at 10 nM concentration. The voltage-dependent steady-state parameters of K+ channel gating were unaffected by the toxin in both channels, but due to the fast association and dissociation kinetics Tst26 slowed the rate of inactivation of Kv1.3 channels. Based on the primary structure, the systematic nomenclature proposed for this peptide is alpha-KTx 4.6. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 50 条
  • [41] Genomic Structure of Two Kv1.3 Channel Blockers from Scorpion Mesobuthus eupeus and Sea Anemone Stichodactyla haddoni and Construction of their Chimeric Peptide as a Novel Blocker
    Maryam Asadi
    Hoda Ayat
    Ali Mohammad Ahadi
    Mohammad Sharif Ranjbar
    Biochemical Genetics, 2022, 60 : 504 - 526
  • [42] Genomic Structure of Two Kv1.3 Channel Blockers from Scorpion Mesobuthus eupeus and Sea Anemone Stichodactyla haddoni and Construction of their Chimeric Peptide as a Novel Blocker
    Asadi, Maryam
    Ayat, Hoda
    Ahadi, Ali Mohammad
    Ranjbar, Mohammad Sharif
    BIOCHEMICAL GENETICS, 2022, 60 (02) : 504 - 526
  • [43] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases
    Beeton, C
    Pennington, MW
    Wulff, H
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, PA
    Chen, CY
    Gutman, GA
    Chandy, KG
    MOLECULAR PHARMACOLOGY, 2005, 67 (04) : 1369 - 1381
  • [44] Designer Ligands Specific for Kv1.3 Channels from a Scorpion Neurotoxin-Based Library
    Takacs, Z.
    Toups, M.
    Kollewe, A.
    Johnson, E.
    Cuello, L. G.
    Driessens, G.
    Koide, A.
    Ponte, C. G.
    Perozo, E.
    Gajewski, T. F.
    Suarez-Kurtz, G.
    Koide, S.
    Strots, O.
    Ostemeyer, J.
    Goldstein, S. A. N.
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 110A - 110A
  • [45] Kv1.3 channels in chronically activated autoreactive T cells: Novel therapeutic target for multiple sclerosis
    Beeton, C
    Wulff, H
    Pennington, M
    Clot-Faybesse, O
    Barbaria, J
    Cahalan, M
    Chandy, KG
    Beraud, E
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 195A - 195A
  • [46] Targeting Kv1.3 potassium channels as a novel strategy to enhance the efficacy of cytarabine treatment in acute leukemia
    Lowinus, T.
    Heidel, F.
    Bose, T.
    Schnoeder, T.
    Schmitz, I
    Seifert, U.
    Fischer, T.
    Schraven, B.
    Bommhardt, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 253 - 253
  • [47] Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for the therapy of autoimmune diseases
    Becton, C
    Pennington, MW
    Singh, S
    Nugent, D
    Crossley, G
    Khaytin, I
    Calabresi, P
    Chandy, KG
    FASEB JOURNAL, 2005, 19 (04): : A344 - A345
  • [48] A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
    Takacs, Zoltan
    Toups, Megan
    Kollewe, Astrid
    Johnson, Erik
    Cuello, Luis G.
    Driessens, Gregory
    Biancalana, Matthew
    Koide, Akiko
    Ponte, Cristiano G.
    Perozo, Eduardo
    Gajewski, Thomas F.
    Suarez-Kurtz, Guilherme
    Koide, Shohei
    Goldstein, Steve A. N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (52) : 22211 - 22216
  • [49] Blockade of KCa3.1 and of Kv1.3 channels as novel immunosuppressive strategy for kidney allograft rejection
    Eichler, I
    Wulff, H
    Varki, N
    Pennington, M
    Chandy, KG
    Köhler, R
    Hoyer, J
    FASEB JOURNAL, 2005, 19 (05): : A1439 - A1439
  • [50] Mechanisms Underlying C-type Inactivation in Kv Channels: Lessons From Structures of Human Kv1.3 and Fly Shaker-IR Channels
    Ong, Seow Theng
    Tyagi, Anu
    Chandy, K. George
    Bhushan, Shashi
    FRONTIERS IN PHARMACOLOGY, 2022, 13